| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |